- Home
- GPRK vs HQL Comparison
GPRK vs HQL Comparison
Compare GPRK & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRK
- HQL
- Stock Information
- Founded
- GPRK 2002
- HQL 1992
- Country
- GPRK Colombia
- HQL United States
- Employees
- GPRK N/A
- HQL N/A
- Industry
- GPRK Oil & Gas Production
- HQL Investment Managers
- Sector
- GPRK Energy
- HQL Finance
- Exchange
- GPRK Nasdaq
- HQL Nasdaq
- Market Cap
- GPRK 397.8M
- HQL 440.3M
- IPO Year
- GPRK N/A
- HQL N/A
- Fundamental
- Price
- GPRK $7.95
- HQL $17.36
- Analyst Decision
- GPRK Hold
- HQL
- Analyst Count
- GPRK 1
- HQL 0
- Target Price
- GPRK $8.50
- HQL N/A
- AVG Volume (30 Days)
- GPRK 1.1M
- HQL 120.9K
- Earning Date
- GPRK 11-05-2025
- HQL 01-01-0001
- Dividend Yield
- GPRK 1.51%
- HQL 11.56%
- EPS Growth
- GPRK N/A
- HQL N/A
- EPS
- GPRK 0.65
- HQL 0.79
- Revenue
- GPRK $525,938,000.00
- HQL N/A
- Revenue This Year
- GPRK N/A
- HQL N/A
- Revenue Next Year
- GPRK N/A
- HQL N/A
- P/E Ratio
- GPRK $11.63
- HQL $17.08
- Revenue Growth
- GPRK N/A
- HQL N/A
- 52 Week Low
- GPRK $5.66
- HQL $11.34
- 52 Week High
- GPRK $11.72
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- GPRK 56.58
- HQL 60.64
- Support Level
- GPRK $7.50
- HQL $16.35
- Resistance Level
- GPRK $8.13
- HQL $17.45
- Average True Range (ATR)
- GPRK 0.30
- HQL 0.42
- MACD
- GPRK -0.07
- HQL -0.01
- Stochastic Oscillator
- GPRK 41.67
- HQL 93.39
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil, and Argentina. The company generates revenue from the sale of crude oil, condensate, and natural gas, net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.